Related Experiment Videos
6-Hydroxydopamine induces thymocyte apoptosis in mice
C W Tsao1, J T Cheng, C L Shen
1Department of Pharmacology, National Cheng Kung University Medical College, Tainan, Taiwan.
Journal of Neuroimmunology
|April 1, 1996
Summary
6-Hydroxydopamine (6-OHDA) causes thymus atrophy and thymocyte apoptosis in mice. Desipramine, a catecholamine uptake blocker, effectively inhibits these 6-OHDA-induced effects.
Area of Science:
- Immunology
- Neuroscience
- Toxicology
Background:
- 6-Hydroxydopamine (6-OHDA) is known to induce noradrenergic nerve degeneration.
- Previous studies suggest 6-OHDA can modulate immune responses.
Purpose of the Study:
- To investigate the effects of 6-OHDA on the mouse thymus.
- To determine if 6-OHDA induces apoptosis in thymocytes.
- To examine the protective role of desipramine against 6-OHDA-induced thymic changes.
Main Methods:
- Intraperitoneal administration of 6-OHDA to mice.
- Flow cytometry to analyze thymocyte subpopulations (CD4, CD8).
- DNA fragmentation assays to detect apoptosis.
- In vivo and in vitro experiments with desipramine pretreatment.
Main Results:
- 6-OHDA treatment led to significant thymus atrophy and reduced thymocyte numbers.
- Significant reduction observed in CD4+CD8+ thymocytes, with decreases in other subpopulations.
- DNA fragmentation confirmed apoptosis in thymocytes.
- Desipramine pretreatment blocked 6-OHDA-induced thymus atrophy, thymocyte loss, and apoptosis.
Conclusions:
- 6-OHDA induces apoptosis in mouse thymocytes both in vivo and in vitro.
- The neurotoxin's apoptotic effect on thymocytes is mediated via catecholamine pathways.
- Desipramine, a catecholamine uptake blocker, mitigates 6-OHDA-induced thymocyte apoptosis.